Morgan Stanley’s Disc Medicine IRON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.86M | Sell |
110,679
-59,531
| -35% | -$3.15M | ﹤0.01% | 3928 |
|
|
2025
Q1 | $8.45M | Buy |
170,210
+20,186
| +13% | +$1M | ﹤0.01% | 3496 |
|
|
2024
Q4 | $9.51M | Buy |
150,024
+80,087
| +115% | +$5.08M | ﹤0.01% | 3453 |
|
|
2024
Q3 | $3.44M | Sell |
69,937
-28,997
| -29% | -$1.42M | ﹤0.01% | 4252 |
|
|
2024
Q2 | $4.46M | Sell |
98,934
-37,700
| -28% | -$1.7M | ﹤0.01% | 3984 |
|
|
2024
Q1 | $8.51M | Sell |
136,634
-88,140
| -39% | -$5.49M | ﹤0.01% | 3477 |
|
|
2023
Q4 | $13M | Buy |
224,774
+175,217
| +354% | +$10.1M | ﹤0.01% | 3707 |
|
|
2023
Q3 | $2.33M | Buy |
49,557
+6,027
| +14% | +$283K | ﹤0.01% | 4285 |
|
|
2023
Q2 | $1.93M | Buy |
43,530
+33,715
| +344% | +$1.5M | ﹤0.01% | 4444 |
|
|
2023
Q1 | $208K | Buy |
9,815
+8,994
| +1,095% | +$191K | ﹤0.01% | 5691 |
|
|
2022
Q4 | $16.3K | Sell |
821
-91
| -10% | -$1.81K | ﹤0.01% | 6757 |
|
|
2022
Q3 | $45K | Sell |
912
-121
| -12% | -$5.97K | ﹤0.01% | 6456 |
|
|
2022
Q2 | $53K | Buy |
1,033
+1
| +0.1% | +$51 | ﹤0.01% | 6580 |
|
|
2022
Q1 | $42K | Buy |
1,032
+217
| +27% | +$8.83K | ﹤0.01% | 6789 |
|
|
2021
Q4 | $71K | Buy |
815
+328
| +67% | +$28.6K | ﹤0.01% | 6630 |
|
|
2021
Q3 | $58K | Sell |
487
-512
| -51% | -$61K | ﹤0.01% | 6649 |
|
|
2021
Q2 | $194K | Buy |
999
+182
| +22% | +$35.3K | ﹤0.01% | 6031 |
|
|
2021
Q1 | $332K | Buy |
+817
| New | +$332K | ﹤0.01% | 5375 |
|